Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer

Niraj K. Gupta; Kirpal Singh; Timothy Glass; Chad Davis; Mark Lybik; Christopher Leagre; Robert H. Liebross; Thomas Dugan; Mark Edwards; Stanley Givens; Julia Compton; Thomas Tigges; Vincent Flanders; Vinay Mathavan; Andrew Isch; David J. Reeves; Gabriel Arevalo; Michael Rowe; Douglas Kaderabek; Maurice Arregui

Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer

Niraj K. Gupta, Kirpal Singh, Timothy Glass, Chad Davis, Mark Lybik, Christopher Leagre, Robert H. Liebross, Thomas Dugan, Mark Edwards, Stanley Givens, Julia Compton, Thomas Tigges, Vincent Flanders, Vinay Mathavan, Andrew Isch, David J. Reeves, Gabriel Arevalo, Michael Rowe, Douglas Kaderabek, Maurice Arregui

Research output: Contribution to conference › Presentation

Abstract

Published abstract from the 2016 ASCO Annual Meeting.

Original language	American English
State	Published - Jan 1 2016
Event	Journal of Clinical Oncology - Duration: Jan 1 2016 → …

Conference

Conference	Journal of Clinical Oncology
Period	1/1/16 → …

Keywords

clinical abstract

Disciplines

Oncology
Pharmacy and Pharmaceutical Sciences

Access to Document

http://meetinglibrary.asco.org/content/166144-176

Cite this

Gupta, N. K., Singh, K., Glass, T., Davis, C., Lybik, M., Leagre, C., Liebross, R. H., Dugan, T., Edwards, M., Givens, S., Compton, J., Tigges, T., Flanders, V., Mathavan, V., Isch, A., Reeves, D. J., Arevalo, G., Rowe, M., Kaderabek, D., & Arregui, M. (2016). Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer. Journal of Clinical Oncology. http://meetinglibrary.asco.org/content/166144-176

Gupta, NK, Singh, K, Glass, T, Davis, C, Lybik, M, Leagre, C, Liebross, RH, Dugan, T, Edwards, M, Givens, S, Compton, J, Tigges, T, Flanders, V, Mathavan, V, Isch, A, Reeves, DJ, Arevalo, G, Rowe, M, Kaderabek, D & Arregui, M 2016, 'Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer', Journal of Clinical Oncology, 1/1/16. <http://meetinglibrary.asco.org/content/166144-176>

@conference{ed0e65583bee42f7a03f70a01c074e46,

title = "Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer",

abstract = " Published abstract from the 2016 ASCO Annual Meeting.",

keywords = "clinical abstract",

author = "Gupta, \{Niraj K.\} and Kirpal Singh and Timothy Glass and Chad Davis and Mark Lybik and Christopher Leagre and Liebross, \{Robert H.\} and Thomas Dugan and Mark Edwards and Stanley Givens and Julia Compton and Thomas Tigges and Vincent Flanders and Vinay Mathavan and Andrew Isch and Reeves, \{David J.\} and Gabriel Arevalo and Michael Rowe and Douglas Kaderabek and Maurice Arregui",

year = "2016",

month = jan,

day = "1",

language = "American English",

note = "Journal of Clinical Oncology ; Conference date: 01-01-2016",

}

TY - CONF

T1 - Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer

AU - Gupta, Niraj K.

AU - Singh, Kirpal

AU - Glass, Timothy

AU - Davis, Chad

AU - Lybik, Mark

AU - Leagre, Christopher

AU - Liebross, Robert H.

AU - Dugan, Thomas

AU - Edwards, Mark

AU - Givens, Stanley

AU - Compton, Julia

AU - Tigges, Thomas

AU - Flanders, Vincent

AU - Mathavan, Vinay

AU - Isch, Andrew

AU - Reeves, David J.

AU - Arevalo, Gabriel

AU - Rowe, Michael

AU - Kaderabek, Douglas

AU - Arregui, Maurice

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Published abstract from the 2016 ASCO Annual Meeting.

AB - Published abstract from the 2016 ASCO Annual Meeting.

KW - clinical abstract

UR - https://digitalcommons.butler.edu/cophs_papers/202

UR - http://meetinglibrary.asco.org/content/166144-176

M3 - Presentation

T2 - Journal of Clinical Oncology

Y2 - 1 January 2016

ER -

Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer

Abstract

Conference

Keywords

Disciplines

Access to Document

Other files and links

Cite this